Low dislocation rates with the use of patient specific "Safe zones" in total hip arthroplasty
- PMID: 34483549
- PMCID: PMC8397909
- DOI: 10.1016/j.jor.2021.08.009
Low dislocation rates with the use of patient specific "Safe zones" in total hip arthroplasty
Abstract
Introduction: The purpose of this study was to compare patient-specific acetabular cup target orientation using functional simulation to the Lewinnek Safe Zone (LSZ) and determine associated rates of postoperative dislocation.
Methods: A retrospective review of 1500 consecutive primary THAs was performed. Inclination, anteversion, pelvic tilt, pelvic incidence, lumbar flexion, and dislocation rates were recorded.
Results: 56% of dynamically planned cups were within LSZ (p < 0.05). 6/1500 (0.4%) of these cups dislocated at two year follow-up, and all were within LSZ.
Conclusion: Optimal acetabular cup positioning using dynamic imaging differs significantly from historical target parameters but results in low rates of dislocation.
Level of evidence: Level III: Retrospective.
Keywords: Cup positioning; Dislocation; Dynamic imaging; Patient-specific components; Technology; Total hip arthroplasty.
© 2021 Professor P K Surendran Memorial Education Foundation. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Abhinav K. Sharma, M.D., declares that he has no conflict of interest. Zlatan Cizmic, M.D., declares that he has no conflict of interest. Douglas A. Dennis, M.D., reports receiving personal fees from Depuy Synthes and 10.13039/100012341Corin Group, stock options in Joint Vue, research support from Depuy Synthes, 10.13039/100012341Corin Group, Porter Adventist Hospital, royalties from Wolters Kluwer publishing, and being a board members for Joint Vue. Stefan W. Kreuzer, M.D., reports receiving personal fees from 10.13039/100012341Corin Group, 10.13039/100009026Smith and Nephew, Medtronic, Pacira, Brain Lab, Intellijoint Surgical, Swift Path, Think Surgical, Shukla, 10.13039/100006338Zimmer/10.13039/100008450Biomet, and Pulse, stock options in Innovative Orthopedic Technologies, INOV8 Orthopedics, INOV8 Surgical, INOV8 Healthcare, K and S Solutions, Orthosensor, Argentum Medical (Silverlon), First Street Surgical Hospital, Texo-Venture, Employers Direct, Alpoza, research support from 10.13039/100012341Corin Group, 10.13039/100009026Smith and Nephew, Depuy, Think Surgical, being a medical/orthopaedic publications governing board member for Journal of Arthroplasty, and being a board member for ISTA, ICJR, Memorial Bone & Joint Research Foundation, Surgical Care Affiliates (Medical Advisory Board), Employers Direct (Medical Advisory Board). Michael A. Miranda, D.O., reports receiving personal fees from 10.13039/100012341Corin Group. Jonathan M. Vigdorchik, M.D., reports receiving personal fees from 10.13039/100012341Corin Group and has received research funding from 10.13039/100012341Corin Group.
Figures
References
-
- Lewinnek G.E., Lewis J.L., Tarr R., Compere C.L., Zimmerman J.R. Dislocations after total hip-replacement arthroplasties. J Bone Joint Surg Am. 1978;60(2):217–220. - PubMed
-
- Bozic K.J., Katz P., Cisternas M., Ono L., Ries M.D., Showstack J. Hospital resource utilization for primary and revision total hip arthroplasty. J Bone Joint Surg Am. 2005;87(3):570–576. - PubMed
-
- DelSole E.M., Vigdorchik J.M., Schwarzkopf R., Errico T.J., Buckland A.J. Total hip arthroplasty in the spinal deformity population: does degree of sagittal deformity affect rates of safe zone placement, instability, or revision? J Arthroplasty. 2017;32(6):1910–1917. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
